Bostal Drug Delivery Co., Ltd
Clinical trials sponsored by Bostal Drug Delivery Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a Once-Every-Few-Weeks shot replace daily pills for schizophrenia? Results expected Aug 2027 (estimated)
- Could a monthly shot ease schizophrenia treatment? Results expected Aug 2027 (estimated)
-
Could a monthly shot ease schizophrenia treatment?
Disease control Not yet recruitingThis trial is testing a new extended-release injection of brexpiprazole, a medication already used for schizophrenia, to see how it behaves in the body and whether it is safe and tolerable. About 16 adults with schizophrenia will receive a single dose of either 45 mg or 100 mg un…
Phase 2/3 • Sponsor: Bostal Drug Delivery Co., Ltd • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a Once-Every-Few-Weeks shot replace daily pills for schizophrenia?
Disease control Not yet recruitingThis trial compares a new long-acting injectable form of the schizophrenia drug cariprazine (called B2227) with the standard oral version, Vraylar. Researchers want to see how the body absorbs and processes each version, and whether the injectable is safe and tolerable. The study…
Phase 2/3 • Sponsor: Bostal Drug Delivery Co., Ltd • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC